Algert Global’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.22M Sell
62,360
-62,770
-50% -$1.54M 0.02% 821
2025
Q4
$3.35M Sell
125,130
-267,772
-68% -$6.9M 0.05% 569
2025
Q3
$10.5M Buy
392,902
+268,612
+216% +$6.94M 0.18% 171
2025
Q2
$2.85M Buy
124,290
+106,990
+618% +$2.65M 0.06% 516
2025
Q1
$502K Buy
+17,300
New +$553K 0.01% 911
2024
Q4
Sell
-66,285
Closed -$3.22M 1168
2024
Q3
$3.22M Buy
+66,285
New +$2.91M 0.09% 408
2024
Q1
Sell
-16,820
Closed -$1.04M 1072
2023
Q4
$1.04M Hold
16,820
0.04% 607
2023
Q3
$774K Sell
16,820
-34,560
-67% -$1.89M 0.04% 624
2023
Q2
$2.95M Buy
51,380
+21,060
+69% +$934K 0.13% 251
2023
Q1
$1.14M Buy
30,320
+21,667
+250% +$710K 0.05% 595
2022
Q4
$242K Sell
8,653
-26,870
-76% -$780K 0.01% 971
2022
Q3
$998K Buy
35,523
+4,790
+16% +$156K 0.06% 545
2022
Q2
$1.07M Buy
30,733
+16,490
+116% +$588K 0.08% 439
2022
Q1
$511K Buy
+14,243
New +$404K 0.03% 804
2016
Q4
Sell
-31,761
Closed -$603K 327
2016
Q3
$603K Buy
+31,761
New +$576K 0.17% 216

Other funds holding AMPH